dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Pinato, David J. |
dc.contributor.author | Lee, Alvin J. X. |
dc.contributor.author | Biello, Federica |
dc.contributor.author | Seguí, Elia |
dc.contributor.author | Aguilar Company, Juan |
dc.contributor.author | Ruiz Camps, Isabel |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Carbó, Anna |
dc.date.accessioned | 2021-08-26T11:00:37Z |
dc.date.available | 2021-08-26T11:00:37Z |
dc.date.issued | 2020-07-08 |
dc.identifier.citation | Pinato DJ, Lee AJX, Biello F, Seguí E, Aguilar-Company J, Carbó A, et al. Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe. Cancers. 2020 Jul 8;12(7):1841. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/6240 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-CoV; Càncer; Mortalitat |
dc.description.sponsorship | D.J.P. is supported by grant funding from the Wellcome Trust Strategic Fund (PS3416) and acknowledges grant support by the Cancer Treatment and Research Trust (CTRT) as well as infrastructural support by the Cancer Research UK Imperial Centre. GG is supported by the AIRC 5 × 1000 Grant, No. 21198, Associazione Italiana per la Ricerca sul Cancro Foundation, Milan, Italy. A.G. is supported by the AIRC IG grant, No. 14230, Associazione Italiana per la Ricerca sul Cancro Foundation, Milan, Italy. A.G., G.G., G.C.A., L.M.C., M.B. (Mattia Bellan), P.P.S., M.P. from the University of Piemonte Orientale acknowledge support from the UPO Aging Project. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;12(7) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | COVID-19 (Malaltia) - Complicacions |
dc.subject | Càncer - Mortalitat |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | /complications |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /mortality |
dc.title | Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers12071841 |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | /complicaciones |
dc.subject.decs | neoplasias |
dc.subject.decs | /mortalidad |
dc.relation.publishversion | https://www.mdpi.com/2072-6694/12/7/1841 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Pinato DJ] Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK. [Lee AJX] Department of Oncology, University College London Hospitals, London, UK. [Biello F] Department of Translational Medicine, Division of Oncology, University of Piemonte Orientale and Maggiore della Carita’ Hospital, Novara, Italy. [Seguí E] Department of Medical Oncology, Hospital Clinic, Barcelona, Spain. [Aguilar-Company J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Carbó A] Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain. [Ruiz-Camps I] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 32650523 |
dc.identifier.wos | 000554884800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |